DGAP-News: MorphoSys Appoints Roland Wandeler, Ph.D., as Chief Commercial Officer

MorphoSys (FSE: MOR; Prime Standard Segment; MDAX & TecDAX; NASDAQ: MOR) announced today the appointment of Roland Wandeler, Ph.D., as Chief Commercial Officer (CCO) of MorphoSys, effective May 5, 2020.